Stock listing
Design Therapeutics, Inc.
Selected listing: DSGN · BOATS · USD · US
Design Therapeutics, Inc. (BOATS:DSGN), Health Technology. Latest release Sep 2, 2026: Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global…
- Ticker
- BOATS:DSGN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
About Design Therapeutics, Inc.
Design Therapeutics, Inc. is a public company traded under the ticker DSGN in the American market. Design Therapeutics focuses on developing innovative therapies for genetic diseases.
Latest news from Design Therapeutics, Inc.
Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference
September 2, 2026
Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial Results
August 3, 2026
Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1
June 30, 2026
Design Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
May 28, 2026
Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia
May 18, 2026
Events
Research Design Therapeutics, Inc.
Design Therapeutics, Inc. company profile
View the public company page for Design Therapeutics, Inc. on 6ix.
Design Therapeutics, Inc. news
Read company news and market updates connected to Design Therapeutics, Inc..
Design Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Design Therapeutics, Inc..